DrugDashboards

doxorubicin hydrochloride

doxorubicin hydrochloride · DOXORUBICIN HYDROCHLORIDE 2 mg/mL · Injection, Suspension, Liposomal · GlaxoSmithKline Manufacturing SpA

NDC 12064-0019-00 · 98 VIAL in 1 CASE / 10 mL in 1 VIAL · DRUG FOR FURTHER PROCESSING · View full market →

Bulk ingredient — not a finished product

This NDC is a raw material (drug for further processing) sold to drug manufacturers or compounders, not a product pharmacies dispense. Retail pricing, TE codes, fragility scores, and shortage reports don't apply to bulk listings — those attach to finished products made from this ingredient.

Medicare Part D

This is a bulk ingredient, not a dispensable product — it is a raw material sold to manufacturers and compounders, so no plan prices it.

How Part D pricing works →

NADAC price per unit

No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.

Supply fragility

Not scored — fragility is computed for NADAC-priced NDCs.

Is this a "specialty" drug?

There's no legal definition — it meets 1 of 6 public criteria. Why that matters →

  • Part D specialty tier
  • Costs ≥ $950/fill
  • Biologic (BLA)
  • Injectable / infused
  • Orphan-drug exclusivity
  • REMS program

Regulatory

Application
—
TE code
—
Approval date
—
Patents / exclusivity
—

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of doxorubicin hydrochloride (Injection, Suspension, Liposomal)

LabelerStrengthFirst seenLast seen
Alembic Pharmaceuticals Inc.DOXORUBICIN HYDROCHLORIDE 2 mg/mLJul 15, 2026Sep 3, 2026
Baxter Healthcare CompanyDOXORUBICIN HYDROCHLORIDE 2 mg/mLJul 15, 2026Sep 3, 2026
BluePoint LaboratoriesDOXORUBICIN HYDROCHLORIDE 2 mg/mLJul 15, 2026Sep 3, 2026
Dr. Reddy's Laboratories Inc.DOXORUBICIN HYDROCHLORIDE 2 mg/mLJul 15, 2026Sep 3, 2026
Lupin Pharmaceuticals, Inc.DOXORUBICIN HYDROCHLORIDE 2 mg/mLJul 15, 2026Sep 3, 2026
GlaxoSmithKline Manufacturing SpADOXORUBICIN HYDROCHLORIDE 2 mg/mLJul 15, 2026Sep 2, 2026
Sagent PharmaceuticalsDOXORUBICIN HYDROCHLORIDE 2 mg/mLJul 15, 2026Sep 2, 2026
Alembic Pharmaceuticals LimitedDOXORUBICIN HYDROCHLORIDE 2 mg/mLJul 15, 2026Aug 31, 2026
Baxter Healthcare CorporationDOXORUBICIN HYDROCHLORIDE 2 mg/mLJul 15, 2026Aug 28, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "doxorubicin hydrochloride — NDC 12064-0019-00," retrieved September 3, 2026, https://drugdashboards.com/drug/12064001900.

Free to cite with attribution — see how the data is put together.